GlassScriptPhysician profile
Christopher P Castro
NPI 1356422406
$332.63
in general payments reported to CMS, 2019-2025
10 companies · $44.83 in 2025
The $44.83 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $57.33 · 2021: $62.44 · 2022: $132 · 2023: $35.65 · 2025: $44.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $80.48.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $80.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $104.91 | 2022 | |
| Collegium Pharmaceutical, INC. | $68.23 | 2019-2022 | |
| Bioventus LLC | $44.83 | 2025 | Durolane |
| Kowa Pharmaceuticals America, INC. | $21.25 | 2023 | Seglentis |
| Sanofi-Aventis U.S. LLC | $18.11 | 2021 | |
| Nalu Medical, INC. | $18.09 | 2021 | |
| Pfizer INC. | $14.67 | 2019 | |
| Horizon Therapeutics Plc | $14.40 | 2023 | Krystexxa |
| Endo Pharmaceuticals INC. | $14.21 | 2019 | |
| Scilex Pharmaceuticals INC. | $13.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Castro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.